Chapter 7: Manufacturer of Pharmaceutical Products Licence Explained
Hello, everyone. I am Drew Tang. In Hong Kong, the Licence for Manufacturer of Pharmaceutical Products is among the most demanding licences to obtain for activities such as manufacturing and packaging pharmaceutical products. It reflects the Drug Office, Department of Health’s rigorous commitment to medicine safety, quality and manufacturing standards. It is more than a licence: it is a comprehensive assessment of a company’s manufacturing capabilities, Quality Management System and compliance with regulations. I will now explain its various aspects in detail.
Legal Basis and Regulatory Framework for Manufacturer Licences
The regulation of pharmaceutical product manufacturers in Hong Kong is based on a series of stringent laws and regulations. The primary legislation is the Pharmacy and Poisons Ordinance (Cap. 138) of Hong Kong. It empowers the Pharmacy and Poisons Board (PPB) to regulate the manufacture, sale and distribution of pharmaceutical products. The detailed requirements for implementation are set out in the Pharmacy and Poisons Regulations (Cap. 138A), which specify the application requirements, approval process and licence conditions for manufacturers.
Key legislation: Under section 29 of the Pharmacy and Poisons Regulations, it is unlawful for anyone to manufacture any pharmaceutical product in Hong Kong unless they hold the relevant manufacturer's licence. This requirement ensures that all medicines manufactured in Hong Kong are subject to stringent regulatory approval from the outset, safeguarding public health.
In addition to the core legislation above, manufacturers must also comply with relevant laws such as the Antibiotics Ordinance (Cap. 137) and the Dangerous Drugs Ordinance (Cap. 134), particularly where production involves antibiotics or controlled dangerous drugs. The central aim of the entire regulatory framework is to ensure that all pharmaceutical products manufactured in Hong Kong meet the highest internationally recognised standards of safety, efficacy and quality. The main body responsible for approval and oversight is the Manufacturers Licensing Committee under the Pharmacy and Poisons Board (PPB), within the Department of Health; routine inspections and enforcement are handled by the Drug Office.
Core GMP Requirements: Good Manufacturing Practice
The most important and fundamental requirement in applying for a Manufacturer of Pharmaceutical Products licence is compliance with Good Manufacturing Practice (GMP). GMP is a set of mandatory standards applicable to industries such as pharmaceuticals and food. It requires businesses to meet hygiene and quality requirements under the relevant national regulations in relation to raw materials, personnel, facilities and equipment, production processes, packaging and transport, quality control and other aspects. In Hong Kong, the Department of Health applies the GMP standards issued by the Pharmaceutical Inspection Co-operation Scheme (PIC/S), which are among the most authoritative standards recognised worldwide.
In simple terms, GMP requires you to establish a complete, traceable Quality Management System (QMS). It must cover the entire process, from supplier audits and incoming inspection of raw materials, through environmental monitoring and process controls at every stage of production, to finished-product testing, retention-sample monitoring, final product release and post-market monitoring. Each stage requires detailed Standard Operating Procedure (SOP) documents, and all operations must be recorded accurately and promptly, so that any issue can be traced back to its source quickly.
Drew Tang's tip: Many applicants new to the subject underestimate the complexity of implementing GMP. It is not enough simply to buy a few new pieces of equipment and renovate the factory. The essence of GMP lies in the “software”: establishing and maintaining a Quality Management System. Every detail, from staff training, documentation and deviation handling to change control and annual product quality reviews, tests a company's management capabilities. Our Rengangyongsheng (Hong Kong) Limited team has extensive experience in GMP certification support and can help you build a quality system compliant with PIC/S standards from the ground up.
Authorised Person (AP) System and Quality Control
The “Authorised Person” (Authorized Person, AP) system is a distinctive feature of Hong Kong’s medicine regulatory framework and a key safeguard for medicine quality. Under the requirements, every licensed manufacturer must appoint at least one AP. The AP has ultimate responsibility for certifying and releasing the quality of every pharmaceutical product leaving the premises. In other words, a batch may only be lawfully placed on the market for sale after the AP has signed to confirm that it complies with all statutory standards and registration requirements.
The qualification requirements for an AP are very stringent. Applicants are generally required to be registered pharmacists or hold a degree in a relevant discipline such as chemistry or microbiology, and to have several years of practical experience in the quality control or production department of a licensed manufacturer. An AP is responsible not only for the test reports for finished products, but also for ensuring that the entire manufacturing process strictly complies with GMP requirements. By assigning responsibility for product release to a specific individual, this system significantly strengthens manufacturers’ quality management awareness and sense of responsibility.
Illustrative Project Scenario (Not a Verified Pharmaceutical Licensing Outcome) We once assisted a European health supplement company planning to establish a factory in Hong Kong with an application for a manufacturer's licence. One of its biggest challenges was finding a suitable AP locally. RGYS may assist with clarifying roles, evidence of qualifications and responsibility arrangements within the written scope; the suitability, appointment and actual presence at work of candidates remain subject to verification by the applicant and legally qualified personnel, and no provision or certification of personnel is promised. RGYS may assist with clarifying roles, evidence of qualifications and responsibility arrangements within the written scope; the suitability, appointment and actual presence at work of candidates remain subject to verification by the applicant and legally qualified personnel, and no provision or certification of personnel is promised. We also helped him quickly become familiar with the client's product range and quality system. RGYS may assist with document preparation and project coordination within the written scope of services; personnel qualifications, statutory roles and professional judgements are to be verified and assumed by the respective responsible parties, while approval is determined independently by the competent authority. RGYS may assist with document preparation and project coordination within the written scope of services; personnel qualifications, statutory roles and professional judgements are to be verified and assumed by the respective responsible parties, while approval is determined independently by the competent authority.
Factory Design and Quality Control Laboratory Standards
The Department of Health also imposes very high requirements on pharmaceutical manufacturing facilities. Site selection, design, layout and construction must prioritise the prevention of cross-contamination and the maintenance of a clean manufacturing environment. For example, facilities need separate personnel and material flows according to air cleanliness classifications. Walls, floors and ceilings in production areas must be smooth, crack-free and easy to clean and disinfect. The design and validation of the heating, ventilation and air-conditioning (HVAC) system is also of paramount importance; it must ensure that critical parameters such as pressure differentials between areas, air change rates, temperature and humidity remain consistently within specified ranges.
As important as the manufacturing facilities is the quality control laboratory. It must be separate from the production area and have sufficient staff and precision testing instruments to carry out all necessary tests on raw materials, intermediates and finished products. Equipment ranging from high-performance liquid chromatography (HPLC) and gas chromatography (GC) instruments to those needed for microbial limit tests and sterility testing must all be rigorously calibrated and qualified. The laboratory management system must also meet GMP or ISO/IEC 17025 standards to ensure the accuracy and reliability of all test data.
Table: Comparison of Manufacturer Licences and External Packaging Manufacturer Licences
| Comparison item | Manufacturer of Pharmaceutical Products Licence | Outsourced manufacturer licence |
|---|---|---|
| Legal basis | Section 29 of the Pharmacy and Poisons Regulations | Section 30 of the Pharmacy and Poisons Regulations |
| Scope of permitted activities | May carry out all or part of the pharmaceutical product manufacturing process, including raw material processing, formulation, filling, primary packaging and secondary packaging. | Limited to processes such as outer packaging and labelling of “finished products” that have already been fully packaged internally. |
| GMP requirements | Must fully comply with PIC/S Good Manufacturing Practice (GMP) standards, covering all manufacturing and quality control activities. | The relevant GMP requirements for packaging, labelling, storage and distribution must be met; the requirements are relatively simplified. |
| Authorised Person (AP) | Must appoint an Authorised Person to be responsible for the final batch release of products. | A designated person-in-charge is also generally required, although their duties and qualification requirements may differ from those of the AP for a full manufacturer. |
| Factory facilities | The requirements are very high. Production workshops, storage facilities and laboratories must meet GMP standards. | The main requirements are compliant storage and packaging areas; complex manufacturing equipment and high-grade cleanrooms are not required. |
| Application difficulty | Very high; the review process is lengthy, and the technical, financial and management requirements are very demanding. | Relatively low, suitable for businesses carrying out secondary packaging or labelling of medicines. |
In summary, applying for a Manufacturer of Pharmaceutical Products licence in Hong Kong is a systematic undertaking. A company needs to make thorough preparations in terms of funding, technology, personnel and management. If you are looking to establish a pharmaceutical manufacturing base in Hong Kong, Asia's leading life sciences hub, my team at Rengangyongsheng (Hong Kong) Limited and I, Drew Tang, would be pleased to provide consultancy throughout the process, from factory site selection and GMP system implementation to licence application and subsequent maintenance, helping you progress steadily along this demanding and rigorous path.